Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Visikol
Visikol is a contract research services company specializing in advanced tissue imaging and cell culture assays to accelerate drug discovery and development. Founded in 2016 and acquired by BICO in…
Visikol
Visikol is a contract research services company specializing in advanced tissue imaging and cell culture assays to accelerate drug discovery and development. Founded in 2016 and acquired by BICO in…
TL;DR
Founded: 2016
Core offering: Contract research services for advanced tissue imaging and 2D/3D cell-culture assays
Commercial products: Tissue-clearing reagents/kits and HUREL Micro Liver primary hepatocyte models
Acquisition: Acquired by BICO in 2021
Clients: Top 20 pharmaceutical companies and >1,000 research labs
Company Overview
Problem Domain
Drug discovery and preclinical research bottlenecks in tissue imaging, pathology analysis, and physiologically relevant in vitro models.
Founded
2016
Industry
Contract Research Organization (CRO); biotechnology / life sciences services
Funding Track Record
Funding event recorded as a grant on Apr 26, 2021
NSF Phase II award recorded Apr 2019
Equity financing round with participation by industry executives Brian Mulhall and Alan Weiss
Investor Signal
“Received multiple non-dilutive grants (NSF, NIH) and completed equity financing with participation from industry executives”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
82,000+
Open Roles
3,800+
New This Week